What is the iTind Center of Excellence Program?
The iTind Center of Excellence Program is designed to enhance patient outcomes and experiences. Urologists included in the iTind Center of Excellence Program have advanced training and experience with the iTind(TM) procedure, and have demonstrated a commitment to care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH). Urologists must meet all program requirements in a calendar year to qualify for the iTind Center of Excellence designation.
Program Requirements
- Completion of iTind™ Training Program
- – Continuum™ Online Training + Sign Off by iTind™ Certified Trainer (~5 cases)
- Completion of a minimum of 25 iTind procedures between January and December 2025
- Submission of de-identified data (baseline and post-treatment IPSS score) on a minimum of 10 iTind™ patients demonstrating mean improvement in IPSS of 30%* or greater compared to baseline average**
- Primary practice website must maintain current and accurate education information on BPH disease state
- Participation in two 30-minute meetings with an Olympus® representative to review de-identified patient outcomes and share best practices
- Participation in one Olympus® iTind™ educational event per calendar year to maintain iTind Center of Excellence status
*The required improvement of 30% or more is in accordance with the FDA guideline for BPH treatments, published in 2021.
**Data collected will be for internal-use only and never published; only used to confirm physician’s competence and experience treating patients with the iTind procedure.
